Of the many types of breast cancer, one of the most rare and trickiest to treat is metaplastic carcinoma. Relatively little is known about how it forms or its long-term prognosis.
Metaplastic breast cancer is a form of invasive ductal cancer, meaning that it forms in the milk ducts and then moves into other tissues of the breast. Inside the tumors of this type of cancer are cells not normally found inside the breast, such as squamous (skin) or osseous (bone) cells. It is also known as carcinoma with metaplasia, or simply metaplastic breast cancer.
Metaplastic sounds very much like metastatic, a more common cancer term, but the two have very different meanings. Metaplastic comes from the Greek phrase for "changed in form,'' which is why it is used to describe cells that appear to have changed into those of another part of the body. Metastatic comes from the Greek phrase for "changed in place,'' describing cancer that has spread from its original site to other areas.
What Are the Symptoms?
Some women with metaplastic breast cancer show no symptoms at all and are identified through routine screening. For others, the symptoms are essentially the same as for other types of breast cancer:
- Lumps or thickening in the breast that were not there before
- Tenderness, discharge or change in appearance of the nipple
- Changes in the appearance of breast skin: redness, scaling, puckering or dimpling
- Irritation of the breast, including redness, swelling and rash
- Unexplained pain in the breast, especially with any of the above symptoms
How Is It Diagnosed?
A number of imaging procedures can be used to determine whether cancer is present. These include:
- Diagnostic mammography. This is much like your routine screening mammogram, except that diagnosing cancer (rather than just checking for cancer) requires more images to be taken and examined.
- Ultrasound. This uses high-frequency sound waves to produce images of breast tissue. These images help doctors to determine whether a lump in the breast is a fluid-filled cyst or a solid tumor.
- Magnetic resonance imaging (MRI). This uses magnetic fields to produce images of the inside of the body.
- Computed tomography (CT or CAT) scan. This creates multiple "slice by slice" pictures of the inside of the body, then combines them into a detailed cross-section picture that can show the presence of tumors.
- Positron-emission tomography (PET) scan. After an injection of radioactive sugar molecules, a PET scan is taken to see which areas of the body are absorbing the sugar most quickly. Because cancer cells thrive on sugar, they "light up" on a PET scan.
- PET-CT scan. This combines the technology of the PET and CT scans, allowing doctors to observe which cells may be cancerous and determine more precisely where they are in the body.
To specifically diagnose metaplastic breast cancer, the breast tissue must be biopsied, meaning that a bit of tissue is removed from the breast (surgically or with a special needle) and examined under a microscope. Biopsy would generally follow some sort of imaging to confirm there is a cancerous tumor present (as opposed to a benign tumor, or a fluid-filled cyst.)
How Is It Treated?
Because it is so rare, a tried-and-true course of action for metaplastic breast cancer is not readily available. Still, as with all cancer, treatment is at first guided by:
- the size and location of the tumor
- whether the cancer has spread
- the patient's overall health, age, etc.
- Testing for hormone receptivity.This helps determine whether the cancer cells will respond well to hormone therapy, such as Tamoxifen, as a treatment option. These drugs work by inhibiting the estrogen receptors on precancerous cells, as estrogen has been linked to breast cancer growth.
- Testing for HER-2 protein.This protein is overproduced in about one fourth of all breast cancers. If this protein is found in a biopsied tumor, then treatment with Herceptin (trastuzumab) may be an option. FDA-approved in 1998, Herceptin binds to the HER-2 protein on cancer cells, enabling the body's own defenses to clear the cancer .
Studies of metaplastic breast cancer cases have shown that the tumors are larger than usual when diagnosed, of a higher stage, and often test negative for hormone receptivity, meaning they will not respond to hormone treatment. Thus, mastectomy followed by chemotherapy has been a frequent course of treatment for this type of cancer. Outcomes have been mixed in the few case reviews done so far, with researchers calling for more follow-up.
Coping With Metaplastic Breast Cancer
Having such a rare form of breast cancer may leave you feeling isolated and confused. Here are some ways to help ease your concerns:
- Find a support group. Your hospital or cancer treatment center may host support groups for breast cancer patients, or at least be able to refer you to one. Even if you are the only one in the group with this specific diagnosis, you are likely to meet women who are going through the same treatments and have the same questions as you do.
- Get online.To connect with others who have metaplastic breast cancer, you can join online communities where patients share their experiences. The American Cancer Society has a great list of online support groups to get you started.
- Consider a clinical trial. Your doctor may know of clinical trials that aim to learn more about your condition. Signing up for these trials may be a good way to help you feel more connected to the process and have a hand in discovering new treatment options. To learn more about the pros and cons of clinical trials and how to find one, consult the National Institutes of Health clinical trial web site http://clinicaltrials.gov/.
Sources: American Cancer Society Staff. "What Is Breast Cancer?." Cancer.org. 13 Sep. 2007. American Cancer Society. 12 May 2008.
National Comprehensive Cancer Network Staff. "Breast Cancer Treatment Guidelines for Patients." NCCN.org. Jul. 2007. National Comprehensive Cancer Network. 12 May 2008.
Rayson, D., et. al.. "Metaplastic Breast Cancer: Prognosis and Response to Systemic Therapy." Annals of Clinical Oncology. 10. 4. Apr. 1999. 413-419.
Neumann, S. "Metaplastic Breast Cancer: Clinical Presentation and Outcome." American Society of Clinical Oncology. 2002 ASCO Annual Meeting, Orlando, FL. May 2002.